Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2025-12-24 @ 3:15 PM
NCT ID:
NCT00404092
Eligibility Criteria:
Inclusion Criteria:
* Immunocompromised due to hematologic malignancies, bone marrow failure syndromes, hematopoietic stem cell transplantation, solid organ transplantation, other conditions resulting in severe neutropenia, HIV infection, prolonged corticosteroid therapy, treatment with other immunosuppressive medications, or other immunocompromising conditions that place patients at risk for invasive fungal infections.
* Evidence of proven or probable invasive aspergillosis, by modified EORTC criteria
Exclusion Criteria:
* Concomitant other systemic antifungal agents are not permitted on study.
* Chronic invasive fungal infection, defined as signs/symptoms of invasive fungal infection present for \> 4 weeks preceding entry into study
* Prior systemic therapy of ≥ 4 days with any polyene anti-fungal agent within 14 days of study enrollment
* Prior systemic therapy of ≥ 4 days with non-polyenes for the current, documented IFI.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00404092
Study Brief:
Protocol Section:
NCT00404092